Medigus to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum in NYC

OMER, Israel, November. 6, 2014 (GLOBE NEWSWIRE) -- Medigus Ltd. (MDGS.TA), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, today announced that Chris Rowland, Chief Executive Officer will present at the Canaccord Genuity Medical Technology & Diagnostics Forum at The Westin Grand Central, New York City. The presentation is scheduled for Thursday November 20, 2014 at 4:00 p.m. EST.

Mr. Rowland will discuss the recent studies published and presented at medical conferences and the implementation of the MUSETM commercialization strategy. A live webcast of the presentation will be available to the public at The webcast will be archived for 90 days following the live presentation at:

Medigus management will be available during the day of the forum for one-on-one meetings. Please contact your Canaccord Genuity representative or Miri Segal at: 917-607-8654 to schedule a meeting.

About the Canaccord Genuity Medical Technology & Diagnostics Forum

This one day event will profile over 75 public and private Med-Tech and Diagnostic companies in Cardiovascular, Aesthetics, Diabetes, Wound Care, Women's Healthcare, Opthalmology, Robots and Imaging, Obesity and Point of Care Diagnostics.

About Medigus

Medigus is a medical device company specializing in developing minimally invasive endosurgical tools and highly innovative imaging solutions. Medigus is a pioneer developer of a unique proprietary endoscopic device, the MUSE system, to treat gastroesophageal reflux disease (GERD), one of the most common chronic diseases in the western world. As an expert in micro-endoscopic devices, Medigus has developed a range of micro CMOS (complementary metal-oxide semiconductor) and CCD (charge-coupled device) video cameras, including micro ScoutCamTM 1.2, which to the best of the company's knowledge, is the smallest in the world. These innovative cameras are suitable for both medical and industrial applications. The MUSETM System incorporates Medigus' revolutionary micro ScoutCamTM technology. Based on its proprietary technologies, Medigus designs and manufactures endoscopy and micro camera systems for partner companies, including major players in the medical device and industrial industries. The company is committed to providing integrated solutions to meet all of its customer's imaging needs. Medigus is traded on the TASE (Tel Aviv Stock Exchange). To learn more about the company's advanced technology, please visit: or

CONTACT: INVESTOR RELATIONS: Miri Segal-Scharia Hayden/ MS-IR LLC 917-607-8654 MEDIA CONTACT: Chantal Beaudry/ Carrie Yamond Lazar Partners Ltd. 212-867-1762

Source:Medigus Ltd.